Monashee Investment Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-264,111
| Closed | -$3.89M | – | 35 |
|
|
2022
Q1 | $3.89M | Sell |
264,111
-35,889
| -12% | -$529K | 1.13% | 9 |
|
|
2021
Q4 | $3.97M | Buy |
300,000
+175,000
| +140% | +$2.32M | 0.98% | 17 |
|
|
2021
Q3 | $2.18M | Buy |
+125,000
| New | +$2.18M | 0.4% | 59 |
|
|
2018
Q4 | – | Hold |
0
| – | -$1.77M | – | 123 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 70 |
|